10.11 USD
▲+0.02+5.42%
2026-08-03
市值
$351.19M
市盈率
—
EPS
-0.28
股息率
—
52 周区间
5.65 – 11.31
成交量
166.42K
Beta
1.07
目标价
15.67
52W 低 5.6552W 高 11.31
价格走势
公司简介
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company’s product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of oto...